Abstract
The kynurenine pathway is the primary route for tryptophan catabolism and has received increasing attention as its association with inflammation and the immune system has become more apparent. This review provides a broad overview of the kynurenine pathway in respiratory diseases, from the initial observations to the characterization of the different cell types involved in the synthesis of kynurenine metabolites and the underlying immunoregulatory mechanisms. With a focus on respiratory infections, the various attempts to characterize the kynurenine/tryptophan (K/T) ratio as an inflammatory marker are reviewed. Its implication in chronic lung inflammation and its exacerbation by respiratory pathogens is also discussed. The emergence of preclinical interventional studies targeting the kynurenine pathway opens the way for the future development of new therapies.
Author supplied keywords
Cite
CITATION STYLE
Pamart, G., Gosset, P., Le Rouzic, O., Pichavant, M., & Poulain-Godefroy, O. (2024, January 1). Kynurenine Pathway in Respiratory Diseases. International Journal of Tryptophan Research. SAGE Publications Ltd. https://doi.org/10.1177/11786469241232871
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.